Study the effect of Sundari Jeevak syrup in Kashtartava (Primary dysmenorrhea)

Phase 2

Completed

• Conditions: Health Condition 1: N944- Primary dysmenorrhea

• Registration Number: CTRI/2020/01/022673
• Lead Sponsor: Multani Pharmaceuticals Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 January 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

1. Females suffering from primary dysmenorrhea more than 3 consecutive cycles.

2. Female presenting primary dysmenorrhea with or without any of the following symptoms associated with- Any kind of pain like headache, backache, abdominal pain, body ache, Nausea and vomiting, Weakness.

3. Psychological symptoms- like anxiety, stress, depression, irritability, restlessness.

4.Willing to participate in the trial.

5.Readiness to sign an informed consent form.

Exclusion Criteria

1. Patients having congenital anomalies, patient is suffering from acute infections, cervical stenosis etc.

2. Patients with chronic illness, patient using an intrauterine contraceptive device, and patient with menorrhagia or any uterine pathology (fibroid, adenomyosis, endometriosis etc.) will be excluded from the study.

3. Lactating female.

4. Individuals participating in any other clinical trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes pain (Primary dysmenorrhea).Timepoint: 90 days

Secondary Outcome Measures

Name	Time	Method
Changes in associated symptomsTimepoint: 90 days